Atjaunināt sīkdatņu piekrišanu

E-grāmata: Diabetes: Clinician's Desk Reference 2nd edition [Taylor & Francis e-book]

, , (St Bartholomews Hospital and Centre for Diabetes, London, UK),
  • Formāts: 244 pages, 67 Tables, black and white; 123 Line drawings, color; 6 Line drawings, black and white; 44 Halftones, color; 2 Halftones, black and white; 167 Illustrations, color; 8 Illustrations, black and white
  • Sērija : Clinician's Desk Reference Series
  • Izdošanas datums: 14-Nov-2022
  • Izdevniecība: CRC Press
  • ISBN-13: 9781003240341
Citas grāmatas par šo tēmu:
  • Taylor & Francis e-book
  • Cena: 209,00 €*
  • * this price gives unlimited concurrent access for unlimited time
  • Standarta cena: 298,57 €
  • Ietaupiet 30%
  • Formāts: 244 pages, 67 Tables, black and white; 123 Line drawings, color; 6 Line drawings, black and white; 44 Halftones, color; 2 Halftones, black and white; 167 Illustrations, color; 8 Illustrations, black and white
  • Sērija : Clinician's Desk Reference Series
  • Izdošanas datums: 14-Nov-2022
  • Izdevniecība: CRC Press
  • ISBN-13: 9781003240341
Citas grāmatas par šo tēmu:
The book explains the underlying pathophysiology of the disease and covers in detail all its main forms and complications. Separate chapters consider the range of treatment options, together with summaries of key clinical trials. Coverage also includes epidemiology and classification, as well as diagnosis, screening, limiting risk, and other aspects of disease management and patient care. The book is illustrated throughout by explanatory diagrams, graphs, tables, and photos.

Key Features:

1. Builds on its strength of having excellent content on long-term management of hyperglycemia by including pancreas and islet transplantation.

2. Contains invaluable information on glucose monitoring for healthcare professionals interested in diabetes.
Preface ix
Acknowledgements ix
Author biographies x
Abbreviations xi
Chapter 1 The nature of diabetes
1(11)
What is diabetes?
1(6)
Forms of diabetes
7(2)
Clinical presentations of diabetes
9(1)
Complications of diabetes
9(1)
The cost of diabetes
10(2)
Chapter 2 Glucose, insulin, and diabetes
12(13)
The role and regulation of glucose
12(6)
The role and regulation of insulin
18(7)
Chapter 3 Type 1 diabetes
25(9)
Epidemiology
25(1)
Causes of type 1 diabetes
26(5)
Development of type 1 diabetes
31(1)
Mortality
31(1)
Screening for potential type 1 diabetes
32(2)
Chapter 4 Type 2 diabetes
34(15)
Epidemiology
34(1)
Causes of type 2 diabetes
35(2)
Associated conditions
37(3)
Metabolic syndrome and obesity
40(2)
Development of type 2 diabetes
42(2)
Incretin hormones
44(1)
The role of amylin
44(1)
Glucotoxicity and lipotoxicity
45(1)
Screening and prevention
46(3)
Chapter 5 Diabetes screening and patient care
49(15)
Management overview
49(1)
Risk factors
49(1)
Annual examination
50(1)
Screening for complications
50(2)
Treating children
52(4)
The elderly person with diabetes
56(2)
Ethnic minorities
58(1)
Patient education and community care
59(1)
Living with diabetes
60(4)
Chapter 6 Diabetes and vascular disease
64(21)
Macrovascular disease
64(1)
Pathogenesis of macrovascular complications
65(1)
Treatment and management principles for macrovascular disease
66(1)
Glucose-lowering drugs and cardiovascular disease
67(6)
Microvascular disease
73(1)
Pathogenesis of microvascular complications
73(4)
Treatment and management principles for microvascular disease
77(1)
Reducing the risk of vascular disease
78(7)
Chapter 7 Diabetic neuropathy
85(10)
Prevalence and classification
85(1)
Diagnosis
86(1)
Chronic sensory polyneuropathy
87(2)
Acute sensory neuropathy
89(1)
Acute motor neuropathy
90(1)
Autonomic neuropathy
90(2)
Treatment and management
92(3)
Chapter 8 Diabetic eye disease
95(8)
Overview
95(1)
Natural history
95(1)
Nonproliferative diabetic retinopathy
96(2)
Proliferative diabetic retinopathy
98(1)
Diabetic maculopathy
99(1)
Cataracts
99(1)
Glaucoma
100(1)
Ocular nerve palsies
100(1)
Treatment and management
100(3)
Chapter 9 Diabetic kidney disease
103(15)
Overview
103(1)
Natural history
103(3)
Diagnosis of nephropathy
106(1)
Urinary tract infections
106(1)
Treatment and management
107(1)
Newer glucose-lowering drugs in diabetic kidney disease
108(7)
Renal replacement therapy
115(2)
Pancreas transplant or islet cell implantation
117(1)
Chapter 10 Skin and musculoskeletal complications of diabetes
118(18)
Skin manifestations of diabetes
118(6)
Musculoskeletal conditions associated with diabetes
124(4)
Diabetic foot
128(6)
Charcot's arthropathy
134(2)
Chapter 11 Infections and diabetes
136(10)
Overview
136(1)
Pathophysiology
136(1)
Infections
137(7)
COVID-19 and diabetes
144(1)
Glycemic control and infection outcomes
145(1)
Chapter 12 Severe diabetic metabolic disturbances
146(11)
Diabetic ketoacidosis
146(4)
Acute management
150(3)
Hyperosmolar hyperglycemic state or hyper-osmolar nonketotic state
153(2)
Brittle diabetes mellitus
155(1)
Recurrent ketoacidosis
156(1)
Lactic acidosis
156(1)
Chapter 13 Long-term management of hyperglycemia
157(9)
Overview
157(1)
Targets of treatment
158(1)
Dietary management
159(1)
Calorie intake
160(1)
Carbohydrates
161(1)
Fats
161(1)
Protein
161(1)
Prescribing a diet
162(1)
Exercise
162(2)
Remission of type 2 diabetes
164(2)
Chapter 14 Noninsulin therapies
166(15)
Overview
166(1)
Oral agents
167(11)
Non-insulin injections
178(3)
Chapter 15 Insulin treatment and pancreatic/islet cell transplantation
181(24)
Overview
181(1)
Indications for insulin treatment
181(1)
Classes of insulin
182(2)
Insulin delivery systems
184(2)
Insulin regimen: type 1 diabetes
186(4)
Continuous glucose monitors (CGMs)
190(1)
Insulin regimen: type 2 diabetes
191(4)
Metabolic instability on insulin
195(1)
Complications: hypoglycemia
196(3)
Treating hypoglycemia
199(1)
Other complications or adverse effects from insulin treatment
200(1)
Pancreas transplantation
201(1)
Islet cell transplant
202(3)
Chapter 16 Special management considerations
205(15)
Inpatient diabetes considerations
205(1)
Diabetes and surgery
206(2)
Conception, contraception, and pregnancy
208(9)
Neonatal problems
217(3)
References 220(8)
Resources: Research and support organizations 228(2)
Glossary 230(8)
Index 238
M. Cecilia Lansang is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, and director of Endocrinology at the Main Campus of Cleveland Clinic, Ohio, USA. She had her endocrine clinical and research fellowship training at the Brigham and Womens Hospital where she stayed on as staff before moving to the University of Florida, and then to Cleveland Clinic. She obtained her degree in Master of Public Health at the Harvard School of Public Health. She is active in research and medical education, serves on journal editorial boards, and focuses clinical work on kidney transplant, inpatient diabetes, and technology.

David Leslie is Professor of Diabetes and Autoimmunity at the Blizard Institute, University of London and Honorary Consultant Physician at St Bartholomews and the Royal London Hospitals, London, UK and Lead Professor on the International Medical Faculty, Campus Biomedico, University of Rome, Italy. He has published 12 books and more than 250 peer-reviewed papers, He was Principle Investigator of three major EU programmes, Wellcome Trust Senior Fellow in Clinical Science and formerly President of the Association of Physicians of Great Britain and Ireland. He has held Visiting Chairs in USA (Chicago and Kansas) and is Emeritus Professor in China (Central South University).

Tahseen Chowdhury is a Clinician in the Department of Diabetes and Metabolism at the Royal London Hospital, in the East End of London. He runs a large specialist Diabetes and Metabolism unit, dealing with diabetes particularly amongst the Bangladeshi community of Tower Hamlets. He has a research / clinical interest in diabetes in South Asians and diabetic kidney disease, and has authored many publications, including books entitled "Diabetes in South Asian people: Explained", "Fatty Liver" and "Diabetes Management in Clinical Practice". He is Honorary Professor at Barts and the London School of Medicine and Dentistry in London, where he runs the metabolism programme for medical students. He qualified from the University of Birmingham and trained in Birmingham and Manchester, before becoming a Consultant Physician in 2000.

Keren Zhou completed her medical degree at Case Western Reserve University. She subsequently trained in Internal Medicine and Endocrinology at the Cleveland Clinic in Ohio, USA, where she is currently staff in the Endocrinology and Metabolism Institute and a Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University. She serves as the Research Director for the Institute and a principal investigator on a number of studies related to diabetes and diabetes technology.